Montelukast as an add-on therapy in bronchopulmonary dysplasia
![]() |
Kim, He Min
(Department of Pediatrics, Yonsei University College of Medicine)
Song, Ji Eun (Department of Pediatrics, Yonsei University College of Medicine) Lee, Soon Min (Department of Pediatrics, Yonsei University College of Medicine) Park, Min Soo (Department of Pediatrics, Yonsei University College of Medicine) Park, Kook In (Department of Pediatrics, Yonsei University College of Medicine) Namgung, Ran (Department of Pediatrics, Yonsei University College of Medicine) Lee, Chul (Department of Pediatrics, Yonsei University College of Medicine) |
1 | Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005;116:1353-60 DOI ScienceOn |
2 | Holgate ST, Peters-Golden M, Panettieri RA, Henderson WR. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clinl Immunol 2003;111:18-34 DOI ScienceOn |
3 | Van Marter LJ. Strategies for preventing bronchopulmonary dysplasia. Curr Opin Pediatr 2005;17:174-80 DOI PUBMED ScienceOn |
4 | Knorr B, Maganti L, Ramakrishnan R, Tozzi CA, Migoya E, Kearns G. Pharmacokinetics and safety of montelukast in children aged 3 to 6 months. J Clin Pharmacol 2006;46:620-7 DOI ScienceOn |
5 | Park MS, Rieger-Fackeldey E, Schanbacher BL, Cook AC, Bauer JA, Rogers LK, et al. Altered expressions of fibroblast growth factor receptors and alveolarization in neonatal mice exposed to 85% oxygen. Pediatr Res 2007;62:652-7 DOI ScienceOn |
6 | Speer CP. Inflammatory mechanisms in neonatal chronic lung disease. Eur J Pediatr 1999;158:18-22 DOI ScienceOn |
7 | Espinosa K, BossY, Stankova J, Rola-Pleszczynski M. CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4. J Allergy Clin Immunol 2003;111:1032-40 DOI ScienceOn |
8 | Drazen JM. Leukotrienes as mediators of airway obstruction. Am J Respir Crit Care Med 1998;158:193-200 ScienceOn |
9 | Speer CP. Pre- and postnatal inflammatory mechanisms in chronic lung disease of preterm infants. Paediatr Respir Rev 2004;5:241-4 DOI ScienceOn |
10 | Bancalari E, Claure N, Sosenko IR. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol 2003;8:63-71 DOI ScienceOn |
11 | Bancalari E, Claure N. Definitions and diagnostic criteria for bronchopulmonary dysplasia. Semin Perinatol 2006;30:164-70 DOI ScienceOn |
12 | Denis D, Fayon MJ, Berger P, Molimard M, De Lara MT, Roux E, et al. Prolonged moderate hyperoxia induces hyperresponsiveness and airway inflammation in newborn rats. Pediatr Res 2001;50:515-9 DOI ScienceOn |
13 | Hosford GE, Koyanagi KS, Leung WI, Olson DM. Hyperoxia increases protein mass of 5-lipoxygenase and its activating protein, flap, and leukotriene B(4) output in newborn rat lungs. Exp Lung Res 2002;28:671-84 DOI ScienceOn |
14 | Bisgaard H. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med 2003;167:379-83 DOI PUBMED ScienceOn |
15 | Nathan RA, Kemp JP. Efficacy of antileukotriene agents in asthma management. Ann Allergy Asthma Immunol 2001; 86:9-17 DOI ScienceOn |
16 | Charafeddine L, D'Angio CT, Phelps DL. Atypical chronic lung disease patterns in neonates. Pediatrics 1999;103:759-65 DOI PUBMED ScienceOn |
17 | Baveja R, Christou H. Pharmacological strategies in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol 2006;30:209-18 DOI ScienceOn |
18 | Devillier P, Baccard N, Advenier C. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma. Phamacol Res 1999;40:3-13 DOI ScienceOn |
19 | Rosewich M, Rose MA, Eickmeier O, Travaci M, Kitz R, Zielen S. Montelukast as add-on therapy to beta-agonists and late airway response. Eur Respir J 2007;30:56-61 DOI ScienceOn |
20 | Groneck P, Gtze-Speer B, Oppermann M, Eiffert H, Speer CP. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 1994;93:712-8 PUBMED ScienceOn |
21 | Sheikh S, Null D, Gentile D, Bimle C. Skoner D, McCoy K. Urinary leukotrine E(4) excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants. Chest 2001;119:1749-54 DOI ScienceOn |
![]() |